The greatest percentage of respondents from both patient groups selected dosing every 2–3 months, followed by once every 1–2 weeks; more biologic-experienced patients expressed a preference for 2–3 month dosing. Low patient satisfaction with treatments like topical medications, phototherapy, and conventional systemic medications was reported due to side effects, inconvenience, and toxicity.

It is advised that patient choices regarding treatment satisfaction and dosing schedule should be included when selecting a tailored therapy for psoriasis for optimal outcomes and medication adherence.

For more information visit DovePress.com.